The Multifaceted Roles of Matrix Metalloproteinases in Lung Cancer

Overview

Journal Front Oncol

Specialty Oncology

Date 2023 Sep 28

PMID 37766868

Authors

Cui Wei

Affiliations

Soon will be listed here.

Abstract

Background: Though the matrix metalloproteinases (MMPs) are widely investigated in lung cancer (LC), however, almost no review systematically clarify their multi-faced roles in LC.

Methods: We investigated the expression of MMPs and their effects on survival of patients with LC, the resistance mechanisms of MMPs in anti-tumor therapy, the regulatory networks of MMPs involved, the function of MMPs inducing CSCLs, MMPs-related tumor immunity, and effects of MMP polymorphisms on risk of LC.

Results: High expression of MMPs was mainly related to poor survival, high clinical stages and cancer metastasis. Role of MMPs in LC are multi-faced. MMPs are involved in drug resistance, induced CSCLs, participated in tumor immunity. Besides, MMPs polymorphisms may increase risk of LC.

Conclusions: MMPs might be promising targets to restore the anti-tumor immune response and enhance the killing function of nature immune cells in LC.

Citing Articles

Clinical effectiveness of Anlotinib combined with PD-1 inhibitors in treating advanced non-small-cell lung carcinoma.

Han Z, Liu W, Wang F Am J Transl Res. 2025; 17(1):674-684.

PMID: 39959242 PMC: 11826207. DOI: 10.62347/WKFJ4968.

Serum Matrix Metalloproteinases and Risk of Urologic Cancers: A Bidirectional Mendelian Randomization Study.

Yang B, Zeng X, Wang H, Feng J, Hou S Am J Mens Health. 2025; 19(1):15579883241311229.

PMID: 39930792 PMC: 11811975. DOI: 10.1177/15579883241311229.

Exploring the mechanism of rosmarinic acid in the treatment of lung adenocarcinoma based on bioinformatics methods and experimental validation.

Zhou C, Zhong R, Zhang L, Yang R, Luo Y, Lei H Discov Oncol. 2025; 16(1):47.

PMID: 39812944 PMC: 11735722. DOI: 10.1007/s12672-025-01784-0.

Advancing Thoracic Surgical Oncology in the Era of Precision Medicine.

Argento G, Rendina E, Maurizi G Cancers (Basel). 2025; 17(1.

PMID: 39796742 PMC: 11720116. DOI: 10.3390/cancers17010115.

Dual-specificity phosphatase 23 functions as a promising prognostic biomarker in non-small cell lung cancer.

Keum S, Lee Y, Kim J, Rhee S Genes Genomics. 2024; 47(3):321-329.

PMID: 39693003 DOI: 10.1007/s13258-024-01604-9.

References

Eun K, Ham S, Kim H . Cancer stem cell heterogeneity: origin and new perspectives on CSC targeting. BMB Rep. 2016; 50(3):117-125. PMC: 5422023. DOI: 10.5483/bmbrep.2017.50.3.222. View

Chowdhury P, Dey P, Ghosh S, Sarma A, Ghosh U . Reduction of metastatic potential by inhibiting EGFR/Akt/p38/ERK signaling pathway and epithelial-mesenchymal transition after carbon ion exposure is potentiated by PARP-1 inhibition in non-small-cell lung cancer. BMC Cancer. 2019; 19(1):829. PMC: 6704719. DOI: 10.1186/s12885-019-6015-4. View

Wang J, Cai Y . Matrix metalloproteinase 2 polymorphisms and expression in lung cancer: a meta-analysis. Tumour Biol. 2012; 33(6):1819-28. DOI: 10.1007/s13277-012-0441-0. View

Su L, Zhou W, Park S, Wain J, Lynch T, Liu G . Matrix metalloproteinase-1 promoter polymorphism and lung cancer risk. Cancer Epidemiol Biomarkers Prev. 2005; 14(3):567-70. DOI: 10.1158/1055-9965.EPI-04-0482. View

An H, Lee Y, Hong S, Kim J, Lee K, Kim Y . The prognostic role of tissue and serum MMP-1 and TIMP-1 expression in patients with non-small cell lung cancer. Pathol Res Pract. 2016; 212(5):357-64. DOI: 10.1016/j.prp.2015.11.014. View

Zhu Y, Spitz M, Lei L, Mills G, Wu X . A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility. Cancer Res. 2001; 61(21):7825-9. View

Chen X, Meng J, Yue W, Yu J, Yang J, Yao Z . Fibulin-3 suppresses Wnt/β-catenin signaling and lung cancer invasion. Carcinogenesis. 2014; 35(8):1707-16. PMC: 4123641. DOI: 10.1093/carcin/bgu023. View

Leifler K, Svensson S, Abrahamsson A, Bendrik C, Robertson J, Gauldie J . Inflammation induced by MMP-9 enhances tumor regression of experimental breast cancer. J Immunol. 2013; 190(8):4420-30. PMC: 3619527. DOI: 10.4049/jimmunol.1202610. View

Li X, Liu C, Ran R, Liu G, Yang Y, Zhao W . Matrix metalloproteinase family gene polymorphisms and lung cancer susceptibility: an updated meta-analysis. J Thorac Dis. 2020; 12(3):349-362. PMC: 7138992. DOI: 10.21037/jtd.2020.01.25. View

10.

Luo K, Yue G, Ko C, Lee J, Gao S, Li L . In vivo and in vitro anti-tumor and anti-metastasis effects of Coriolus versicolor aqueous extract on mouse mammary 4T1 carcinoma. Phytomedicine. 2014; 21(8-9):1078-87. DOI: 10.1016/j.phymed.2014.04.020. View

11.

Liu J, Shen W, Tang Y, Zhou J, Li M, Zhu W . Proteasome inhibitor MG132 enhances the antigrowth and antimetastasis effects of radiation in human nonsmall cell lung cancer cells. Tumour Biol. 2014; 35(8):7531-9. DOI: 10.1007/s13277-014-2012-z. View

12.

Shen T, Hsia T, Chao C, Chen W, Chen C, Chen W . The Contribution of Promoter Polymorphisms in Lung Cancer. Anticancer Res. 2017; 37(7):3563-3567. DOI: 10.21873/anticanres.11726. View

13.

Sternlicht M, Werb Z . How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol. 2001; 17:463-516. PMC: 2792593. DOI: 10.1146/annurev.cellbio.17.1.463. View

14.

Zhang L, Mi Y, Cao Q, Wang W, Qin C, Wei J . Update analysis of studies on the MMP-9 -1562 C>T polymorphism and cancer risk. Mol Biol Rep. 2011; 39(4):3435-41. DOI: 10.1007/s11033-011-1115-5. View

15.

Elkington P, Shiomi T, Breen R, Nuttall R, Ugarte-Gil C, Walker N . MMP-1 drives immunopathology in human tuberculosis and transgenic mice. J Clin Invest. 2011; 121(5):1827-33. PMC: 3083790. DOI: 10.1172/JCI45666. View

16.

Kucukguven A, Khalil R . Matrix metalloproteinases as potential targets in the venous dilation associated with varicose veins. Curr Drug Targets. 2013; 14(3):287-324. PMC: 3584231. View

17.

Wu D, Deng S, Liu T, Han R, Zhang T, Xu Y . TGF-β-mediated exosomal lnc-MMP2-2 regulates migration and invasion of lung cancer cells to the vasculature by promoting MMP2 expression. Cancer Med. 2018; 7(10):5118-5129. PMC: 6198203. DOI: 10.1002/cam4.1758. View

18.

Kang J, Kang H, Kim I, Lee H, Ha J, Yeo C . Curcumin sensitizes human lung cancer cells to apoptosis and metastasis synergistically combined with carboplatin. Exp Biol Med (Maywood). 2015; 240(11):1416-25. PMC: 4935310. DOI: 10.1177/1535370215571881. View

19.

McColgan P, Sharma P . Polymorphisms of matrix metalloproteinases 1, 2, 3 and 9 and susceptibility to lung, breast and colorectal cancer in over 30,000 subjects. Int J Cancer. 2009; 125(6):1473-8. DOI: 10.1002/ijc.24441. View

20.

Yu G, Herazo-Maya J, Nukui T, Romkes M, Parwani A, Juan-Guardela B . Matrix metalloproteinase-19 promotes metastatic behavior in vitro and is associated with increased mortality in non-small cell lung cancer. Am J Respir Crit Care Med. 2014; 190(7):780-90. PMC: 4299607. DOI: 10.1164/rccm.201310-1903OC. View